Los puntos clave no están disponibles para este artículo en este momento.
APPROXIMATELY 10,000 autologous hematopoietic stem cell (HSC) transplants are performed worldwide each year for malignant diseases.11 Results of randomized trials in recent years suggest that high-dose chemotherapy followed by infusion of autologous HSCs can offer prolonged disease-free survival
Guillaume et al. (Tue,) studied this question.